Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography

J Frohlich, M Dobiášová

. 2003 ; 49 (11) : 1873-1880.

Language English Country United States

Document type Research Support, Non-U.S. Gov't

Grant support
NA6590 MZ0 CEP Register

Digital library NLK
Full text - Část
Source

E-resources Online

NLK ProQuest Central from 2002-12-01 to 2022-04-30
Open Access Digital Library from 1955-02-01
Nursing & Allied Health Database (ProQuest) from 2002-12-01 to 2022-04-30
Health & Medicine (ProQuest) from 2002-12-01 to 2022-04-30
Public Health Database (ProQuest) from 2002-12-01 to 2022-04-30

BACKGROUND: We examined the predictive value of various clinical and biochemical markers for angiographically defined coronary artery disease (aCAD). Specifically, we assessed the value of the ratio of plasma triglyceride (TGs) to HDL-cholesterol (HDL-C) and the fractional esterification rate of cholesterol in plasma depleted of apolipoprotein B (apoB)-containing lipoproteins (FER(HDL)), a functional marker of HDL and LDL particle size. METHODS: Patients (788 men and 320 women) undergoing coronary angiography were classified into groups with positive [aCAD(+)] and negative [aCAD(-)] findings. Patient age, body mass index, waist circumference, blood pressure (BP), medications, drinking, smoking, exercise habits, and plasma total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-unesterified cholesterol, HDL-C, TGs, FER(HDL), apoB, log(TG/HDL-C), and TC/HDL-C were assessed. Lipids and apoproteins were measured by standard laboratory procedures; FER(HDL) was determined by a radioassay. RESULTS: Members of the aCAD(+) group were older and had a higher incidence of smoking and diabetes than those in the aCAD(-) group. The aCAD(+) group also had higher TG, apoB, FER(HDL), and log(TG/HDL-C) and lower HDL-C values. aCAD(+) women had greater waist circumference and higher plasma TC and TC/HDL-C. aCAD(+) men, but not women, had higher plasma LDL-C. In the multivariate logistic model, the significant predictors of the presence of aCAD(+) were FER(HDL), age, smoking, and diabetes. If only laboratory tests were included in the multivariate logistic model, FER(HDL) appeared as the sole predictor of aCAD(+). Log(TG/HDL-C) was an independent predictor when FER(HDL) was omitted from multivariate analysis. CONCLUSIONS: FER(HDL) was the best laboratory predictor of the presence of coronary atherosclerotic lesions.

000      
00000naa a2200000 a 4500
001      
bmc12011461
003      
CZ-PrNML
005      
20120426123052.0
007      
ta
008      
120403s2003 xxu f 000 0eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Frohlich, Jiří, $d 1942- $7 xx0064831 $u Department of Pathology and Laboratory Medicine, University of British Columbia, Healthy Heart Program/Lipid Clinic, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada. jifr@interchange.ubc.ca
245    10
$a Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography / $c J Frohlich, M Dobiášová
520    9_
$a BACKGROUND: We examined the predictive value of various clinical and biochemical markers for angiographically defined coronary artery disease (aCAD). Specifically, we assessed the value of the ratio of plasma triglyceride (TGs) to HDL-cholesterol (HDL-C) and the fractional esterification rate of cholesterol in plasma depleted of apolipoprotein B (apoB)-containing lipoproteins (FER(HDL)), a functional marker of HDL and LDL particle size. METHODS: Patients (788 men and 320 women) undergoing coronary angiography were classified into groups with positive [aCAD(+)] and negative [aCAD(-)] findings. Patient age, body mass index, waist circumference, blood pressure (BP), medications, drinking, smoking, exercise habits, and plasma total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-unesterified cholesterol, HDL-C, TGs, FER(HDL), apoB, log(TG/HDL-C), and TC/HDL-C were assessed. Lipids and apoproteins were measured by standard laboratory procedures; FER(HDL) was determined by a radioassay. RESULTS: Members of the aCAD(+) group were older and had a higher incidence of smoking and diabetes than those in the aCAD(-) group. The aCAD(+) group also had higher TG, apoB, FER(HDL), and log(TG/HDL-C) and lower HDL-C values. aCAD(+) women had greater waist circumference and higher plasma TC and TC/HDL-C. aCAD(+) men, but not women, had higher plasma LDL-C. In the multivariate logistic model, the significant predictors of the presence of aCAD(+) were FER(HDL), age, smoking, and diabetes. If only laboratory tests were included in the multivariate logistic model, FER(HDL) appeared as the sole predictor of aCAD(+). Log(TG/HDL-C) was an independent predictor when FER(HDL) was omitted from multivariate analysis. CONCLUSIONS: FER(HDL) was the best laboratory predictor of the presence of coronary atherosclerotic lesions.
590    __
$a bohemika - dle Pubmed
650    02
$a mladiství $7 D000293
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a biologické markery $x krev $7 D015415
650    02
$a cholesterol $x krev $x metabolismus $7 D002784
650    02
$a HDL-cholesterol $x krev $7 D008076
650    02
$a LDL-cholesterol $x krev $7 D008078
650    02
$a koronární angiografie $7 D017023
650    02
$a nemoci koronárních tepen $x diagnóza $x krev $x radiografie $7 D003324
650    02
$a esterifikace $7 D004951
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a multivariační analýza $7 D015999
650    02
$a prediktivní hodnota testů $7 D011237
650    02
$a regresní analýza $7 D012044
650    02
$a triglyceridy $x krev $7 D014280
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dobiášová, Milada $7 xx0062268
773    0_
$t Clinical Chemistry $x 0009-9147 $g Roč. 49, č. 11 (2003), s. 1873-1880 $p Clin Chem $w MED00001129
773    0_
$p Clin Chem $g 49(11):1873-80, 2003 Nov $x 0009-9147
910    __
$a ABA008 $b A 1418 $y 2
990    __
$a 20120403134701 $b ABA008
991    __
$a 20120426123028 $b ABA008
999    __
$a ok $b bmc $g 904831 $s 768420
BAS    __
$a 3
BMC    __
$a 2003 $b 49 $c 11 $d 1873-1880 $x MED00001129 $i 0009-9147 $m Clinical chemistry $n Clin Chem
GRA    __
$a NA6590 $p MZ0
LZP    __
$a 2011-B

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...